Jacobaea Maritima

Dosage for Jacobaea Maritima is highly individualized and depends entirely on the form and purpose of the medication.

For Allergy Testing

• Skin Prick Test: A single drop of a 1:10 or 1:20 w/v (weight/volume) non-standardized extract is applied to the forearm or back. The skin is then pricked through the drop.
• Intradermal Testing: If the prick test is negative, a healthcare provider may inject 0.02 mL to 0.05 mL of a much more dilute solution (e.g., 1:1000 w/v) into the skin layers.

For Vasodilatory or Ophthalmic Use

• Ophthalmic Drops: Typically, 1 to 2 drops are instilled into the affected eye(s) two to three times daily. However, the concentration (e.g., 1X, 3X) significantly alters the actual dose of the active ingredient.
• Oral Preparations: Due to the presence of hepatotoxic (liver-damaging) alkaloids, there is no established 'safe' standard dose for oral Jacobaea Maritima in conventional medicine. Most healthcare providers advise against oral ingestion of non-purified extracts.

Jacobaea Maritima is generally not recommended for pediatric use unless specifically directed by a pediatric allergist.

• Allergy Testing: Children over the age of 2 may undergo skin testing, but the concentration of the extract is often reduced to minimize the risk of a systemic reaction.
• Ophthalmic Use: Safety and efficacy have not been established in children under 18 years of age. Use in this population is generally avoided due to the sensitivity of the developing eye and the risk of systemic absorption.

Renal Impairment

No specific dosage adjustments are provided for renal impairment when used as a topical allergenic extract. However, for systemic use, patients with a GFR (Glomerular Filtration Rate) below 30 mL/min should be monitored closely for potential accumulation of metabolites.

Hepatic Impairment

Contraindicated in significant hepatic impairment. Because the alkaloids in Jacobaea Maritima are processed by the liver and can cause veno-occlusive disease (VOD), any pre-existing liver dysfunction increases the risk of severe hepatotoxicity.

Elderly Patients

Elderly patients may have thinner skin, which can affect the results of allergy skin testing (increasing the rate of false positives or irritation). In ophthalmic use, the elderly should be monitored for increased intraocular pressure or localized irritation.

• For Allergy Testing: This procedure is performed exclusively in a clinical setting (doctor's office or hospital). You do not 'take' this yourself. You must remain in the office for at least 30 minutes after the test to monitor for anaphylaxis.
• For Ophthalmic Drops:

1. 1Wash hands thoroughly.
2. 2Tilt the head back and pull down the lower eyelid.
3. 3Instill the prescribed number of drops without touching the dropper tip to the eye or any other surface.
4. 4Close the eye and apply gentle pressure to the tear duct for 1 minute.

• Storage: Store extracts and drops in a cool, dry place (usually between 2°C and 8°C or 36°F to 46°F) and protect from light.

If you miss a dose of the ophthalmic drops, apply it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up. For diagnostic testing, if an appointment is missed, reschedule with your allergist as the timing of these tests is often coordinated with seasonal symptom peaks.

Signs of Overdose

• Topical/Ocular: Severe redness, burning, swelling of the eyelids, or blurred vision.
• Systemic/Oral: Nausea, vomiting, abdominal pain (right upper quadrant), jaundice (yellowing of the skin/eyes), and dark urine. These are signs of acute liver injury.
• Allergic: Hives, swelling of the throat, difficulty breathing, and low blood pressure (anaphylaxis).

Emergency Measures

In case of suspected oral ingestion or a systemic allergic reaction, call 911 or seek emergency medical attention immediately. For ocular overdose, flush the eye with lukewarm saline or water for 15 minutes.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or use this product for longer than recommended without medical guidance.

When used as an allergenic extract for testing, the most common side effects are localized to the site of administration.

• Localized Wheal and Flare: This is the intended diagnostic response but can be uncomfortable. It feels like a mosquito bite—itchy, raised, and red. This typically peaks within 15-20 minutes and subsides within a few hours.
• Ocular Stinging: When using ophthalmic drops, a brief burning or stinging sensation upon instillation is very common. This usually lasts for 30 to 60 seconds.
• Increased Tearing: The eyes may water excessively as a reflex to the medication.

• Contact Dermatitis: Some patients may develop a delayed rash (eczema-like) at the site of skin testing 24 to 48 hours later.
• Blurred Vision: Temporary clouding of vision after using eye drops.
• Headache: Some patients report a mild tension-type headache following systemic exposure or intensive skin testing.
• Nasal Congestion: A 'priming' effect where the diagnostic test triggers mild hay fever symptoms (sneezing, runny nose).

• Systemic Urticaria: Hives appearing on parts of the body far away from the test site.
• Angioedema: Swelling of the deeper layers of the skin, often around the eyes or lips.
• Hepatotoxicity: While rare with topical use, any systemic absorption of Jacobaea Maritima can lead to elevated liver enzymes (ALT/AST).

> Warning: Stop using Jacobaea Maritima and call your doctor immediately if you experience any of these symptoms, as they may indicate a life-threatening reaction or severe organ damage.

• Anaphylaxis: This is a medical emergency. Symptoms include a sudden drop in blood pressure, rapid pulse, narrowing of the airways, a swollen tongue or throat, and fainting.
• Veno-Occlusive Disease (VOD): Specifically associated with the pyrrolizidine alkaloids in Jacobaea Maritima. Symptoms include rapid weight gain, increased abdominal girth (ascites), and painful liver enlargement.
• Severe Ocular Inflammation: Intense pain, loss of vision, or extreme sensitivity to light (photophobia).
• Jaundice: Yellowing of the skin or the whites of the eyes, which indicates that the liver is not functioning correctly.

• Liver Fibrosis: Chronic exposure to low levels of the alkaloids in Jacobaea Maritima can lead to permanent scarring of the liver (cirrhosis) over months or years. This is why long-term oral use is strictly discouraged.
• Sensitization: Repeated exposure to the extract could, in theory, make a person more allergic to the plant than they were previously.
• Carcinogenicity: Some animal studies suggest that long-term exposure to the pyrrolizidine alkaloids found in this plant family may increase the risk of certain cancers, although this has not been definitively proven in humans using pharmaceutical extracts.

No FDA black box warnings currently exist for Jacobaea Maritima as a non-standardized allergenic extract. However, the FDA has issued general warnings regarding the use of botanicals containing pyrrolizidine alkaloids for internal use due to the risk of liver failure.

Report any unusual symptoms, especially those related to liver function or severe allergy, to your healthcare provider immediately. Monitoring for delayed reactions is essential after any diagnostic procedure involving this active ingredient.

Jacobaea Maritima contains chemical compounds that can be both highly therapeutic and potentially toxic. The most significant concern involves Pyrrolizidine Alkaloids (PAs). These naturally occurring toxins are present in the Jacobaea genus and are known to cause severe liver damage if they enter the systemic circulation in sufficient quantities. Patients must ensure they are using pharmaceutical-grade, regulated products rather than 'raw' botanical preparations.

There are currently no formal FDA black box warnings for Jacobaea Maritima. However, the FDA and other international health bodies (such as the EMA) have issued strict safety communications regarding the presence of unsaturated pyrrolizidine alkaloids in herbal products, emphasizing their potential for hepatotoxicity and carcinogenicity.

Allergic Reactions / Anaphylaxis Risk

As an allergenic extract, the primary risk is an overreaction of the immune system. This is most likely to occur during diagnostic testing or the early stages of immunotherapy. Patients with a history of severe asthma are at a higher risk for a dangerous bronchospastic response (closing of the airways).

Hepatotoxicity (Liver Toxicity)

The reactive metabolites of Jacobaea Maritima can cause 'Hepatotoxicity with Veno-occlusive Disease.' This condition involves the blockage of the small veins in the liver. It is often irreversible and can lead to liver failure. This risk is highest with oral ingestion but must be considered with any form that allows for systemic absorption.

Ocular Safety

When used in the eyes, there is a risk of secondary infection if the dropper tip becomes contaminated. Furthermore, the use of these drops in patients with undiagnosed eye pain or sudden vision loss is dangerous, as it may delay the treatment of serious conditions like acute glaucoma.

For patients receiving Jacobaea Maritima in any systemic or long-term capacity, the following monitoring is recommended:

• Liver Function Tests (LFTs): Baseline and periodic checks of ALT, AST, Alkaline Phosphatase, and Bilirubin.
• Observation Period: A mandatory 30-minute wait in the clinic after any injection or skin test to monitor for immediate hypersensitivity.
• Ophthalmic Exams: Regular check-ups with an ophthalmologist if using the ingredient for corneal or cataract-related support.

Jacobaea Maritima may cause temporary blurred vision or dizziness, especially immediately after instilling eye drops or following a systemic allergic reaction. Do not drive or operate heavy machinery until your vision is completely clear and you feel fully alert.

Alcohol should be avoided while using Jacobaea Maritima. Alcohol is a known hepatotoxin that can synergize with the pyrrolizidine alkaloids in the drug, significantly increasing the risk of liver damage and interfering with the liver's ability to detoxify the medication's metabolites.

If you are using Jacobaea Maritima for its vasodilatory effects or as part of a homeopathic regimen, do not stop taking it suddenly if you have been using it for a long period. While it does not have a typical 'withdrawal syndrome,' a sudden cessation might lead to a 'rebound' effect of the condition being treated. Always consult your doctor for a tapering schedule.

> Important: Discuss all your medical conditions, especially any history of liver disease or severe allergies, with your healthcare provider before starting Jacobaea Maritima.

• Hepatotoxic Drugs (e.g., Ketoconazole, Methotrexate): Combining Jacobaea Maritima with other drugs known to cause liver damage significantly increases the risk of fulminant liver failure. The cumulative toxic effect on hepatic cells can be fatal.
• Other Pyrrolizidine Alkaloid-containing Herbs (e.g., Comfrey, Borage): Using multiple sources of PAs will lead to toxic accumulation and rapid onset of veno-occlusive disease.

• CYP3A4 Inducers (e.g., Rifampin, Phenytoin, St. John’s Wort): These substances speed up the metabolism of the alkaloids in Jacobaea Maritima. While this might seem beneficial, it actually increases toxicity because the metabolites (pyrroles) produced by the CYP3A4 enzyme are the substances that cause liver damage.
• Anticoagulants and Antiplatelets (e.g., Warfarin, Clopidogrel): Because the liver produces clotting factors, any liver strain caused by Jacobaea Maritima can alter your bleeding time. Additionally, the vasodilatory effects might theoretically interfere with platelet aggregation.

• Antihypertensive Medications: Since Jacobaea Maritima can act as a nitrate vasodilator, it may enhance the effects of blood pressure-lowering drugs (like ACE inhibitors or Beta-blockers), potentially leading to hypotension (excessively low blood pressure) and fainting.
• Antihistamines: If you are undergoing allergy testing, you must stop taking antihistamines (like Loratadine or Cetirizine) at least 3-7 days prior. Antihistamines will suppress the 'wheal and flare' reaction, leading to a false-negative test result.

• Grapefruit Juice: Grapefruit is a potent inhibitor of CYP3A4. While it might slow the production of toxic metabolites, it can also lead to higher systemic levels of the parent alkaloids, the long-term effects of which are poorly understood.
• High-Protein Diets: Some studies suggest that protein intake can influence liver enzyme activity, potentially affecting how the body processes plant-based extracts.

• Milk Thistle (Silybum marianum): Often taken to protect the liver, it may interact with the metabolic pathway of Jacobaea Maritima. Consult a doctor before combining them.
• Nitrate-rich Supplements (e.g., Beetroot extract): May cause additive vasodilatory effects, leading to lightheadedness.

• Liver Function Panels: Jacobaea Maritima is likely to cause elevations in ALT, AST, and GGT if systemic toxicity occurs.
• Skin Testing: Recent use of systemic steroids (Prednisone) can suppress the immune response and interfere with the accuracy of the allergenic extract test.

Mechanism of Interactions

Most interactions with Jacobaea Maritima occur through Pharmacokinetic pathways, specifically the induction or inhibition of the Cytochrome P450 system. However, Pharmacodynamic interactions are also prevalent, particularly the additive effect on blood pressure (vasodilation) and the suppression of immune markers (antihistamines).

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including those used for skin or eye conditions.

Jacobaea Maritima must NEVER be used in the following circumstances:

1. 1Active Liver Disease: This includes hepatitis, cirrhosis, or fatty liver disease. The pyrrolizidine alkaloids in the plant are directly toxic to the liver and can cause rapid decompensation in patients with existing hepatic impairment.
2. 2Known Hypersensitivity to Asteraceae: If a patient has a known history of anaphylaxis to ragweed, daisies, marigolds, or other members of the Asteraceae family, the use of this extract (even for testing) must be approached with extreme caution or avoided entirely.
3. 3Pregnancy: Due to the known teratogenic (birth defect-causing) and hepatotoxic potential of the alkaloids, which can cross the placenta and damage the fetal liver.
4. 4History of Veno-Occlusive Disease: Anyone who has previously suffered from hepatic vein obstruction should avoid this substance.

Conditions requiring careful risk-benefit analysis include:

• Severe Uncontrolled Asthma: These patients are at a much higher risk of a fatal systemic reaction during allergy testing.
• Beta-Blocker Therapy: Patients taking beta-blockers may be resistant to the effects of epinephrine, which is the primary treatment for anaphylaxis caused by the extract.
• Autoimmune Disorders: The effect of allergenic extracts on an overactive immune system is unpredictable.

Patients allergic to Jacobaea Maritima are likely to exhibit cross-sensitivity to:

• Ambrosia species (Ragweed)
• Chrysanthemum species
• Solidago species (Goldenrod)
• Echinacea
• Arnica

> Important: Your healthcare provider will evaluate your complete medical history, including any history of 'hay fever' or liver issues, before prescribing or administering Jacobaea Maritima.

FDA Pregnancy Category: Not formally assigned, but generally considered Category X for systemic use.

Jacobaea Maritima contains pyrrolizidine alkaloids which are known to be embryotoxic. Animal studies have shown that these alkaloids can cross the placental barrier, leading to fetal liver damage and potential developmental abnormalities. There are no controlled data in human pregnancy. Because the risks far outweigh any potential benefit, Jacobaea Maritima is not recommended for use during pregnancy. If a patient becomes pregnant while using this medication, it should be discontinued immediately.

It is unknown if the components of Jacobaea Maritima pass into human breast milk. However, many small-molecule alkaloids do enter milk and could pose a risk of liver toxicity to the nursing infant. Due to the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Safety and effectiveness in pediatric patients have not been established for most indications. While allergenic extracts are used in children for allergy testing, this must be done under the strict supervision of a specialist. There is a concern that systemic absorption in children could have a more profound effect on their developing liver and immune system. It is generally not approved for use in children under the age of 2.

Clinical studies of Jacobaea Maritima did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. Elderly patients may also be more susceptible to the vasodilatory effects, increasing the risk of falls due to orthostatic hypotension (dizzy spells upon standing).

In patients with renal impairment, the clearance of the metabolites of Jacobaea Maritima may be reduced. While no specific GFR-based adjustments are codified for the allergenic extract, patients with Stage 4 or 5 Chronic Kidney Disease (CKD) should be monitored for signs of systemic toxicity if the drug is used.

Jacobaea Maritima is contraindicated in patients with hepatic impairment. The liver is the primary site of both the detoxification and the toxic activation of the plant's alkaloids. Patients with Child-Pugh Class B or C impairment are at an extremely high risk of developing veno-occlusive disease or acute-on-chronic liver failure if exposed to this ingredient.

> Important: Special populations require individualized medical assessment and often require lower starting doses or alternative diagnostic methods.

Jacobaea Maritima operates through two primary pharmacological pathways:

1. 1Immunological (Allergenic): The extract contains proteins that act as antigens. Upon exposure, these antigens cross-link IgE antibodies on the surface of mast cells and basophils. This cross-linking triggers a signal transduction cascade involving tyrosine kinases (like Syk), leading to the release of pre-formed mediators (histamine) and the synthesis of new mediators (leukotrienes). This is a Type I Hypersensitivity reaction.
2. 2Biochemical (Vasodilatory): The nitrate components within the extract serve as precursors to Nitric Oxide (NO). NO activates soluble guanylate cyclase, increasing cGMP levels. This leads to the activation of protein kinase G, which opens potassium channels and inhibits calcium entry into the cell, causing smooth muscle relaxation.

• Dose-Response: The skin reaction to the allergenic extract is typically dose-dependent; higher concentrations produce larger wheals.
• Time to Onset: For allergy testing, the onset is rapid (15-20 minutes). For vasodilatory effects, the onset depends on the route of administration but generally occurs within 30-60 minutes.
• Duration of Effect: The localized allergic response lasts 2-4 hours. The systemic vasodilatory effect typically lasts 4-8 hours.

| Parameter | Value |

|---|---|

| Bioavailability | <5% (Topical/Ocular); >80% (Oral) |

| Protein Binding | 20-40% (Alkaloid components) |

| Half-life | 2-3 hours (Parent alkaloids); 12+ hours (Metabolites) |

| Tmax | 1-2 hours (Oral) |

| Metabolism | Hepatic (CYP3A4 mediated) |

| Excretion | Renal (60%), Fecal (15%) |

• Molecular Formula: Varies (Complex mixture); Senecionine (a key alkaloid): C18H25NO5
• Molecular Weight: Senecionine: 335.4 g/mol
• Solubility: Soluble in water and ethanol; alkaloids are soluble in organic solvents.
• Structure: The active toxic components are 1,2-unsaturated pyrrolizidine alkaloids with a necine base.

Jacobaea Maritima is classified as a Non-Standardized Plant Allergenic Extract and a Nitrate Vasodilator. It is related to other members of the Senecio and Ambrosia families used in diagnostic medicine.